What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

Electronic patient‑reported outcomes and machine learning in predicting immune‑related adverse events of immune checkpoint inhibitor therapies

Deep learning systems have widely presented promising results in cancer diagnostics [1] and for Kaiku Health, machine learning (ML) based approaches are not anything new. Previously, Oulu University Hospital (OYS) and Kaiku Health have shown that it is possible to predict both symptom and adverse event onset and continuation in patients receiving immune checkpoint inhibitor...

Read the article

Kaiku Health to develop digital patient monitoring for melanoma with leading global medicines company

Kaiku Health, the developer of digital health intervention platform in oncology, today announced it will develop digital patient monitoring and management for melanoma patients in collaboration with Novartis, a leading global medicines company. Melanoma is less common than other types of skin cancer, but it can more easily spread to other parts of the body....

Read the article

Elekta launches Kaiku Health in the United States

In May 2020, Elekta announced that it will further develop its focus on cancer care providers and their patients through its acquisition of Kaiku Health. A key element of the acquisition was that the Kaiku platform can be integrated with Elekta’s MOSAIQ® Oncology Information System. Kaiku Health is now available in the US as a...

Read the article

Kaiku Health has taken its first steps to predict treatment response of cancer patients for immune checkpoint inhibitor therapies with machine learning

Kaiku Health has taken its first steps to tackle the big issue related to the challenge of identifying which patients are likely to benefit from immune checkpoint inhibitor (ICI) therapies. The unfortunate fact is that not all eligible patients respond to these therapies at all, and for some of those who have a response, it...

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
+358 445512744


Get in touch with us

Interested in learning more about Kaiku Health? Send us a note